Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D02JYA
|
||||
| Former ID |
DNAP001277
|
||||
| Drug Name |
Raxibacumab
|
||||
| Drug Type |
Monoclonal antibody
|
||||
| Indication | Anthrax [ICD9: 22; ICD10:A00-B99] | Approved | [1] | ||
| Company |
GlaxoSmithKline
|
||||
| CAS Number |
CAS 565451-13-0
|
||||
| Target and Pathway | |||||
| Target(s) | Protective antigen | Target Info | Modulator | [1] | |
| Pathway Interaction Database | Cellular roles of Anthrax toxin | ||||
| Reactome | Uptake and function of anthrax toxins | ||||
| References | |||||
| REF 1 | Modulation of innate and adaptive immune responses by tofacitinib (CP-690,550). J Immunol. 2011 Apr 1;186(7):4234-43. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.